Skip to content Skip to footer
Dr. Vivek Lal, Founder & CEO at ResBiotic Shares Insights from the New Preclinical Data for resB Lung Support Presented at DDW 2022

Dr. Vivek Lal, Founder & CEO at ResBiotic Shares Insights from the New Preclinical Data for resB Lung Support Presented at DDW 2022

Shots: Dr. Vivek talked about the results from the preclinical study of its probiotic and herbal supplement for lung health in a poster presented at DDW 2022 He also spoke about how resB helps to decrease MMP-9 inflammatory pathway activity, associated with tissue damage and neutrophilic inflammation The interview provides a deep understanding of Resbiotic’s…

Read more

Thoughtspot_Sunaina Anand

Nutraceuticals Under Evaluation for COVID-19 Prevention and Treatment

The pandemic has led to the identification of some promising nutraceuticals for the management and prevention of Covid-19. Nutraceuticals with their immune-boosting potential can amplify the body's defense system against the virus. For the past numerous decades, the medicinal action of natural compounds has gained focus as an alternate or adjuvant therapy approach in treating…

Read more

Sign Up to Our Newsletter

Be the first to know the latest updates

[mc4wp_form id="13387" element_id="style-1"]